LER & CER: letter to Editor Rheumatology
Reply to: Behçet’s disease: an MHC-I-opathy?
D. Mcgonagle1, S.Z. Aydin2, A. Gül3, A. Mahr4, H. Direskeneli5
- Section of Musculoskeletal Diseases, The Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Chapel Allerton Hospital, Leeds, UK.
- Rheumatology Division, University of Ottawa, Canada. drsibelaydin@gmail.com
- Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Turkey.
- Department of Internal Medicine, Hospital Saint-Louis, University Paris 7 – Diderot, Paris, France.
- Department of Internal Medicine, Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey.
CER9628
2017 Vol.35, N°2 ,Suppl.104
PI 0006
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 28421994 [PubMed]
Received: 01/06/2016
Accepted : 01/06/2016
In Press: 14/04/2017
Published: 29/05/2017


